BioSpace News Archive

Pharm Country

Precipio Reschedules Q2-2021 Shareholder Update CallDue to a schedule conflict, the call is moved to Thursday August 26th at 5:00PM EST

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be rescheduling its Q2-2021 update call from Monday August 23rd to Thursday, August 26th at 5:00 PM ET due to a schedule conflict.

August 20, 2021
·
3 min read
Transdermal Drug Delivery Systems Market: Diabetes Application Segment to Lead Global Market

Transdermal is a route of administration, wherein drugs are administered through the skin to achieve systemic distribution

August 20, 2021
·
5 min read
Narcolepsy Drugs Market Asia Pacific has shown large potential and is anticipated to rise at rapid growth rate to 2028

The narcolepsy drug pipeline has been dotted with medications that can target several symptoms of neurological sleep disorder.

August 20, 2021
·
4 min read
Insulin Delivery Pens Market: Increased prevalence of diabetes to drive the market

People suffering from diabetes make use of insulin pens to administer insulin in their bodies.

August 20, 2021
·
5 min read
Dyschromia Therapeutics Market: Increase in awareness about the importance of personal appearance to drive the market

Dyschromia refers to a condition marked by any irregular discoloration on the skin, hair or nails, which can present as single or multiple light or dark patches on the skin.

August 20, 2021
·
5 min read
Dry Needling Treatment Market: Competitive Landscape & Regional Analysis

Used as treatment method for a number of conditions, dry needling is gaining prominence worldwide and this is set to drive the global dry needling treatment market on an upward growth trajectory.

August 20, 2021
·
5 min read
Business

Ultimovacs ASA: Second Quarter 2021 Result Presentation

Ultimovacs ASA, a clinical stage leader in immune stimulatory vaccines for cancer, announces its second quarter 2021 results.

August 20, 2021
·
2 min read
BioForest

Cardiac Dimensions® Announces Launch of Its Optimized U.S. Pivotal Trial - The EMPOWER Trial

Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced the launch of the U.S. pivotal study The EMPOWER Trial.

August 20, 2021
·
4 min read
Deals

Epizyme Announced Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Epizyme today announced that the Company approved the grant of equity awards to two new employees with a grant date of August 16, 2021, as equity inducement awards outside of the company’s 2013 Stock Incentive Plan and material to the employees’ acceptance of employment with the Company.

August 20, 2021
·
2 min read
Biotech Beach

Establishment Labs to Launch Motiva Flora Tissue Expander at London Breast Meeting on September 2, 2021

Establishment Labs Holdings Inc. today announced it will host an event on September 2, 2021 marking the official launch of the company’s Motiva Flora ® tissue expander in Europe and other CE Mark countries.

August 20, 2021
·
6 min read